Company Data

Skye Bioscience Inc Com

Advanced Market Data

Ticker

SKYE

Current Price

$0.019 -2.56%

Market Cap

$17.3M

Price Target

Refer to Report

Volume

1.3M

52wk Range

$0.011 - $0.0819

Advanced Market Data

Overview

Skye Bioscience Inc is a biopharmaceutical company. It is focused on the development of novel cannabinoid- based therapies with strong clinical and commercial differentiation for the treatment of glaucoma and other diseases with significant unmet needs.

Other Considerations

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

$0.1488

$0.14(6.29%)

3.0M

685.1K

$0.131 - $14.7

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Imugene Ltd.

IUGNF (OTO)

$0.13

$0.15(-13.33%)

828.1M

10.7K

$0.0837 - $0.404

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PsyBio Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PsyBio Therapeutics

PsyBio Therapeutics

PSYBF (OTO)

$0.03355

$0.04(-12.86%)

3.7M

2.4K

$0.029 - $0.3192

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Axcella Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Axcella Therapeutics

Axcella Therapeutics

AXLA (Nasdaq)

$0.87

$0.83(4.69%)

31.7M

32.4K

$0.7006 - $3.04

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Psybio Therapeutics Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Psybio Therapeutics Corp.

Psybio Therapeutics Corp.

PSYB:CA (CDX)

$0.055

6.1M

97.7K

$0.04 - $0.375

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data